For GDM patients carrying breast cancer genetic susceptibility genes (such as germline mutations in BRCA1/2), hyperinsulinemia, and chronic inflammation may further impair the DNA damage repair capacity through the PI3K/Akt pathway (58, 59). The gene discussed is BRCA1; the disease is hyperinsulinism.